Cargando…
(Ultra-)low dosing of rituximab in rheumatoid arthritis: chances and challenges
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931796/ https://www.ncbi.nlm.nih.gov/pubmed/33693305 http://dx.doi.org/10.1093/rap/rkab007 |
| _version_ | 1783660361614884864 |
|---|---|
| author | den Broeder, Alfons A den Broeder, Nathan Verhoef, Lise M |
| author_facet | den Broeder, Alfons A den Broeder, Nathan Verhoef, Lise M |
| author_sort | den Broeder, Alfons A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7931796 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79317962021-03-09 (Ultra-)low dosing of rituximab in rheumatoid arthritis: chances and challenges den Broeder, Alfons A den Broeder, Nathan Verhoef, Lise M Rheumatol Adv Pract Editorial Oxford University Press 2021-02-04 /pmc/articles/PMC7931796/ /pubmed/33693305 http://dx.doi.org/10.1093/rap/rkab007 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial den Broeder, Alfons A den Broeder, Nathan Verhoef, Lise M (Ultra-)low dosing of rituximab in rheumatoid arthritis: chances and challenges |
| title | (Ultra-)low dosing of rituximab in rheumatoid arthritis: chances and challenges |
| title_full | (Ultra-)low dosing of rituximab in rheumatoid arthritis: chances and challenges |
| title_fullStr | (Ultra-)low dosing of rituximab in rheumatoid arthritis: chances and challenges |
| title_full_unstemmed | (Ultra-)low dosing of rituximab in rheumatoid arthritis: chances and challenges |
| title_short | (Ultra-)low dosing of rituximab in rheumatoid arthritis: chances and challenges |
| title_sort | (ultra-)low dosing of rituximab in rheumatoid arthritis: chances and challenges |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931796/ https://www.ncbi.nlm.nih.gov/pubmed/33693305 http://dx.doi.org/10.1093/rap/rkab007 |
| work_keys_str_mv | AT denbroederalfonsa ultralowdosingofrituximabinrheumatoidarthritischancesandchallenges AT denbroedernathan ultralowdosingofrituximabinrheumatoidarthritischancesandchallenges AT verhoeflisem ultralowdosingofrituximabinrheumatoidarthritischancesandchallenges |